News

NorthStar Medical Radioisotopes Expands Business Platform with New, Patient-focused, Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) Services Unit

View more

Nov 17, 2022

¹⁷⁷Lu-PSMA and ²²⁵Ac-PSMA Radionuclide Therapy for mCRPC

View more

Nov 15, 2022

Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003

View more

Nov 15, 2022

PET/MRI shows promise for imaging infection, inflammation

View more

Nov 14, 2022

PET/MRI Machine Learning Model Can Eliminate Sentinel Lymph Node Biopsy in Majority of Breast Cancer Patients

View more

Nov 14, 2022

Targeting refractory prostate cancer: A novel radiopharmaceutical hits the bullseye

View more

Nov 11, 2022